Cargando…

Gastric Cancer Surgery During the Pandemic: What It Costs?

BACKGROUND: From the early days of 2020, the COVID-19 pandemic continues to change whole life all around the world. Oncological patients are the most affected populations since these days. Because of decreasing numbers in surgery and endoscopy, gastric cancer patients had difficulties in treatment a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yazici, Hilmi, Eren, Ayse, Uprak, Tevfik Kivilcim, Sahan, Cihan, Esmer, Ahmet Cem, Yegen, Sevket Cumhur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608237/
https://www.ncbi.nlm.nih.gov/pubmed/34811648
http://dx.doi.org/10.1007/s12029-021-00751-6
_version_ 1784602711901077504
author Yazici, Hilmi
Eren, Ayse
Uprak, Tevfik Kivilcim
Sahan, Cihan
Esmer, Ahmet Cem
Yegen, Sevket Cumhur
author_facet Yazici, Hilmi
Eren, Ayse
Uprak, Tevfik Kivilcim
Sahan, Cihan
Esmer, Ahmet Cem
Yegen, Sevket Cumhur
author_sort Yazici, Hilmi
collection PubMed
description BACKGROUND: From the early days of 2020, the COVID-19 pandemic continues to change whole life all around the world. Oncological patients are the most affected populations since these days. Because of decreasing numbers in surgery and endoscopy, gastric cancer patients had difficulties in treatment and diagnoses. Therefore, the early and long-term results may be affected during the pandemic. In this study, we aimed to evaluate pandemia effects on gastric cancer surgery in a single center. PATIENTS-METHODS: Patients were categorized as the COVID group and the Pre-COVID group. Patients who received neoadjuvant chemotherapy were excluded from the study. In the COVID period, 50 patients underwent gastric cancer surgery, while 64 were operated on in the pre-COVID period. Patients’ demographics and clinical and pathological outcomes were evaluated. RESULTS: There was no statistically significant difference in both periods among patient characteristics such as age, gender, and body mass index. Pre-operative laboratory results were similar between two groups. Although there was no difference in operation types, an increase was detected in Clavien-Dindo grade 3 and higher complications during the COVID period. During the pandemic, there was a significant difference in the pathological outcomes. Peritoneal cytology-positive patients were hıgher in the COVID group. More lymphovascular invasions were also detected in the COVID period. Finally, it resulted stage differences between two groups. CONCLUSION: Because of COVID-19’s heavy burden on healthcare system, delays in the diagnosis and treatment of oncological patients may occur. Therefore, this may be affected pathological and survival outcomes of cancer patients. Finally, further investigations are needed.
format Online
Article
Text
id pubmed-8608237
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-86082372021-11-23 Gastric Cancer Surgery During the Pandemic: What It Costs? Yazici, Hilmi Eren, Ayse Uprak, Tevfik Kivilcim Sahan, Cihan Esmer, Ahmet Cem Yegen, Sevket Cumhur J Gastrointest Cancer Original Research BACKGROUND: From the early days of 2020, the COVID-19 pandemic continues to change whole life all around the world. Oncological patients are the most affected populations since these days. Because of decreasing numbers in surgery and endoscopy, gastric cancer patients had difficulties in treatment and diagnoses. Therefore, the early and long-term results may be affected during the pandemic. In this study, we aimed to evaluate pandemia effects on gastric cancer surgery in a single center. PATIENTS-METHODS: Patients were categorized as the COVID group and the Pre-COVID group. Patients who received neoadjuvant chemotherapy were excluded from the study. In the COVID period, 50 patients underwent gastric cancer surgery, while 64 were operated on in the pre-COVID period. Patients’ demographics and clinical and pathological outcomes were evaluated. RESULTS: There was no statistically significant difference in both periods among patient characteristics such as age, gender, and body mass index. Pre-operative laboratory results were similar between two groups. Although there was no difference in operation types, an increase was detected in Clavien-Dindo grade 3 and higher complications during the COVID period. During the pandemic, there was a significant difference in the pathological outcomes. Peritoneal cytology-positive patients were hıgher in the COVID group. More lymphovascular invasions were also detected in the COVID period. Finally, it resulted stage differences between two groups. CONCLUSION: Because of COVID-19’s heavy burden on healthcare system, delays in the diagnosis and treatment of oncological patients may occur. Therefore, this may be affected pathological and survival outcomes of cancer patients. Finally, further investigations are needed. Springer US 2021-11-22 2022 /pmc/articles/PMC8608237/ /pubmed/34811648 http://dx.doi.org/10.1007/s12029-021-00751-6 Text en © Springer Science+Business Media, LLC, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Research
Yazici, Hilmi
Eren, Ayse
Uprak, Tevfik Kivilcim
Sahan, Cihan
Esmer, Ahmet Cem
Yegen, Sevket Cumhur
Gastric Cancer Surgery During the Pandemic: What It Costs?
title Gastric Cancer Surgery During the Pandemic: What It Costs?
title_full Gastric Cancer Surgery During the Pandemic: What It Costs?
title_fullStr Gastric Cancer Surgery During the Pandemic: What It Costs?
title_full_unstemmed Gastric Cancer Surgery During the Pandemic: What It Costs?
title_short Gastric Cancer Surgery During the Pandemic: What It Costs?
title_sort gastric cancer surgery during the pandemic: what it costs?
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608237/
https://www.ncbi.nlm.nih.gov/pubmed/34811648
http://dx.doi.org/10.1007/s12029-021-00751-6
work_keys_str_mv AT yazicihilmi gastriccancersurgeryduringthepandemicwhatitcosts
AT erenayse gastriccancersurgeryduringthepandemicwhatitcosts
AT upraktevfikkivilcim gastriccancersurgeryduringthepandemicwhatitcosts
AT sahancihan gastriccancersurgeryduringthepandemicwhatitcosts
AT esmerahmetcem gastriccancersurgeryduringthepandemicwhatitcosts
AT yegensevketcumhur gastriccancersurgeryduringthepandemicwhatitcosts